May 24, 2021 / 06:00PM GMT
Esther P. Rajavelu - UBS Investment Bank, Research Division - Analyst & Executive Director
Good day, everyone, and thank you for joining us at the Virtual UBS Healthcare Conference on our fireside chat with the Denali management team.
I am Esther Rajavelu covering SMID cap biotech here at UBS, and joining me today are Ryan Watts, CEO; and Carole Ho, Chief Medical Officer of Denali. Thank you both for your time. We are excited to have you join us.
Ryan J. Watts - Denali Therapeutics Inc. - Co-Founder, President, CEO & Director
Esther, thank you so much. Really great to be here. Looking forward to discussing Denali and really appreciate your interest in our approach to defeating degeneration.
Esther P. Rajavelu - UBS Investment Bank, Research Division - Analyst & Executive Director
Great. So Ryan perhaps you can start us off with a brief overview of what you're most excited about as you look at the next, I don't know, 6 to 12 to 18 months for Denali.
Ryan J. Watts -
Denali Therapeutics Inc at UBS Global Healthcare Virtual Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers